pregnancy on tirzepatide and Pregnancy: Safety Facts Restarting tirzepatide after pregnancy :

The rate and pattern of weight regain after stopping tirzepatide and semaglutide are broadly similar approximately 0.8 kg per month with return to baseline weight within about 18 months

Eli Lilly submitted the orforglipron NDA to the FDA in Q1 2026 following ATTAIN Phase 3 trial data showing 14.7% body weight reduction at 45mg positioning the worlds first oral small molecule GLP-1 receptor agonist for obesity for anticipated FDA approval in late 2026 or 2027

While many patients turn to international online pharmacies for savings, Zepbound poses a unique challenge: it requires refrigerated storage and shipment

You negligent a-hole

Patients with higher initial body fat percentages generally lose a greater proportion of fat relative to lean tissue

So you feel wired, but you're not actually moving around